These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 25851994)

  • 61. miR-149 Suppresses Breast Cancer Metastasis by Blocking Paracrine Interactions with Macrophages.
    Sánchez-González I; Bobien A; Molnar C; Schmid S; Strotbek M; Boerries M; Busch H; Olayioye MA
    Cancer Res; 2020 Mar; 80(6):1330-1341. PubMed ID: 31911555
    [TBL] [Abstract][Full Text] [Related]  

  • 62. microRNA-200c downregulates XIAP expression to suppress proliferation and promote apoptosis of triple-negative breast cancer cells.
    Ren Y; Han X; Yu K; Sun S; Zhen L; Li Z; Wang S
    Mol Med Rep; 2014 Jul; 10(1):315-21. PubMed ID: 24821285
    [TBL] [Abstract][Full Text] [Related]  

  • 63. BRCA mutations cause reduction in miR-200c expression in triple negative breast cancer.
    Erturk E; Cecener G; Tezcan G; Egeli U; Tunca B; Gokgoz S; Tolunay S; Tasdelen I
    Gene; 2015 Feb; 556(2):163-9. PubMed ID: 25445393
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Genetic and epigenetic down-regulation of microRNA-212 promotes colorectal tumor metastasis via dysregulation of MnSOD.
    Meng X; Wu J; Pan C; Wang H; Ying X; Zhou Y; Yu H; Zuo Y; Pan Z; Liu RY; Huang W
    Gastroenterology; 2013 Aug; 145(2):426-36.e1-6. PubMed ID: 23583431
    [TBL] [Abstract][Full Text] [Related]  

  • 65. miR-146a and miR-638 in BRCA1-deficient triple negative breast cancer tumors, as potential biomarkers for improved overall survival.
    Zavala V; Pérez-Moreno E; Tapia T; Camus M; Carvallo P
    Cancer Biomark; 2016; 16(1):99-107. PubMed ID: 26835710
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Antagonizing miR-218-5p attenuates Wnt signaling and reduces metastatic bone disease of triple negative breast cancer cells.
    Taipaleenmäki H; Farina NH; van Wijnen AJ; Stein JL; Hesse E; Stein GS; Lian JB
    Oncotarget; 2016 Nov; 7(48):79032-79046. PubMed ID: 27738322
    [TBL] [Abstract][Full Text] [Related]  

  • 67. MicroRNA-127 is downregulated by Tudor-SN protein and contributes to metastasis and proliferation in breast cancer cell line MDA-MB-231.
    Zhao X; Duan Z; Liu X; Wang B; Wang X; He J; Yao Z; Yang J
    Anat Rec (Hoboken); 2013 Dec; 296(12):1842-9. PubMed ID: 24155205
    [TBL] [Abstract][Full Text] [Related]  

  • 68. miR-519d-mediated downregulation of STAT3 suppresses breast cancer progression.
    Deng X; Zhao Y; Wang B
    Oncol Rep; 2015 Oct; 34(4):2188-94. PubMed ID: 26238950
    [TBL] [Abstract][Full Text] [Related]  

  • 69. PDL1 And LDHA act as ceRNAs in triple negative breast cancer by regulating miR-34a.
    Huang X; Xie X; Wang H; Xiao X; Yang L; Tian Z; Guo X; Zhang L; Tang H; Xie X
    J Exp Clin Cancer Res; 2017 Sep; 36(1):129. PubMed ID: 28915924
    [TBL] [Abstract][Full Text] [Related]  

  • 70. miR-200a inhibits migration of triple-negative breast cancer cells through direct repression of the EPHA2 oncogene.
    Tsouko E; Wang J; Frigo DE; Aydoğdu E; Williams C
    Carcinogenesis; 2015 Sep; 36(9):1051-60. PubMed ID: 26088362
    [TBL] [Abstract][Full Text] [Related]  

  • 71. miR-21: A gene of dual regulation in breast cancer.
    Zhang C; Liu K; Li T; Fang J; Ding Y; Sun L; Tu T; Jiang X; Du S; Hu J; Zhu W; Chen H; Sun X
    Int J Oncol; 2016 Jan; 48(1):161-72. PubMed ID: 26549725
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Caprin-1 is a novel microRNA-223 target for regulating the proliferation and invasion of human breast cancer cells.
    Gong B; Hu H; Chen J; Cao S; Yu J; Xue J; Chen F; Cai Y; He H; Zhang L
    Biomed Pharmacother; 2013 Sep; 67(7):629-36. PubMed ID: 23953883
    [TBL] [Abstract][Full Text] [Related]  

  • 73. FBXL14 abolishes breast cancer progression by targeting CDCP1 for proteasomal degradation.
    Cui YH; Kim H; Lee M; Yi JM; Kim RK; Uddin N; Yoo KC; Kang JH; Choi MY; Cha HJ; Kwon OS; Bae IH; Kim MJ; Kaushik N; Lee SJ
    Oncogene; 2018 Oct; 37(43):5794-5809. PubMed ID: 29973690
    [TBL] [Abstract][Full Text] [Related]  

  • 74. MiR-203 suppresses tumor growth and invasion and down-regulates MiR-21 expression through repressing Ran in esophageal cancer.
    Zhang F; Yang Z; Cao M; Xu Y; Li J; Chen X; Gao Z; Xin J; Zhou S; Zhou Z; Yang Y; Sheng W; Zeng Y
    Cancer Lett; 2014 Jan; 342(1):121-9. PubMed ID: 24001611
    [TBL] [Abstract][Full Text] [Related]  

  • 75. E3 ubiquitin ligase CHIP attenuates cellular proliferation and invasion abilities in triple-negative breast cancer cells.
    Xu J; Wang H; Li W; Liu K; Zhang T; He Z; Guo F
    Clin Exp Med; 2020 Feb; 20(1):109-119. PubMed ID: 31845129
    [TBL] [Abstract][Full Text] [Related]  

  • 76. GSE1 negative regulation by miR-489-5p promotes breast cancer cell proliferation and invasion.
    Chai P; Tian J; Zhao D; Zhang H; Cui J; Ding K; Liu B
    Biochem Biophys Res Commun; 2016 Feb; 471(1):123-8. PubMed ID: 26828271
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Identification of microRNA-214 as a negative regulator of colorectal cancer liver metastasis by way of regulation of fibroblast growth factor receptor 1 expression.
    Chen DL; Wang ZQ; Zeng ZL; Wu WJ; Zhang DS; Luo HY; Wang F; Qiu MZ; Wang DS; Ren C; Wang FH; Chiao LJ; Pelicano H; Huang P; Li YH; Xu RH
    Hepatology; 2014 Aug; 60(2):598-609. PubMed ID: 24616020
    [TBL] [Abstract][Full Text] [Related]  

  • 78. MicroRNA-326 functions as a tumor suppressor in colorectal cancer by targeting the nin one binding protein.
    Wu L; Hui H; Wang LJ; Wang H; Liu QF; Han SX
    Oncol Rep; 2015 May; 33(5):2309-18. PubMed ID: 25760058
    [TBL] [Abstract][Full Text] [Related]  

  • 79. miR-96 promotes tumor proliferation and invasion by targeting RECK in breast cancer.
    Zhang J; Kong X; Li J; Luo Q; Li X; Shen L; Chen L; Fang L
    Oncol Rep; 2014 Mar; 31(3):1357-63. PubMed ID: 24366472
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Suppressive role of miR-502-5p in breast cancer via downregulation of TRAF2.
    Sun LL; Wang J; Zhao ZJ; Liu N; Wang AL; Ren HY; Yang F; Diao KX; Fu WN; Wan EH; Mi XY
    Oncol Rep; 2014 May; 31(5):2085-92. PubMed ID: 24677135
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.